2011 Vol.29, N°1 - Table of contents

January-February 2011

Imaging

CER4454
2011,29,1
Pg. 0001-0005

Free to view

Ultrasound imaging for the rheumatologist. XXXI. Sonographic assessment of the foot in patients with rheumatoid arthritis.
L. Riente, A. Delle Sedie, C.A. Scirè, E. Filippucci, G. Meenagh, A. Iagnocco, N. Possemato, G. Valesini, W. Grassi, C. Montecucco, S. Bombardieri

Full Papers

CER3718
2011,29,1
Pg. 0006-0012

Free to view

Effects of rituximab therapy on quality of life in patients with primary Sjögren's syndrome
V. Devauchelle-Pensec, J. Morvan, A.-C. Rat, S. Jousse-Joulin, Y. Pennec, J.-O. Pers, C. Jamin, Y. Renaudineau, I. Quintin-Roué, B. Cochener, P. Youinou, A. Saraux

CER3926
2011,29,1
Pg. 0013-0018

Free to view

Association of polymorphisms in the programmed cell death 1 (PD-1) and PD-1 ligand genes with ankylosing spondylitis in a Chinese population
Q. Yang, Y. Liu, D. Liu, Y. Zhang, K. Mu

CER3933
2011,29,1
Pg. 0019-0025

Free to view

Lack of association between RETN rs1862513 polymorphism and cardiovascular disease in rheumatoid arthritis patients
L. Rodriguez-Rodriguez, M. Garcia-Bermudez, C. Gonzalez-Juanatey, T.R. Vazquez-Rodriguez, J.A. Miranda-Filloy, B. Fernandez-Gutierrez, J. Llorca, J. Martin, M.A. Gonzalez-Gay

CER3958
2011,29,1
Pg. 0026-0034

Free to view

Differences in biologic dose-escalation, non-biologic and steroid intensification among three anti-TNF agents: evidence from clinical practice
R.J. Moots, B. Haraoui, M. Matucci-Cerinic, P.L. Van Riel, J. Kekow, T. Schaeverbeke, A. Davis, M.A. Tedeschi, B. Freundlich, D.J. Chang, A. Singh

CER3954
2011,29,1
Pg. 0035-0042

Free to view

Effects of naproxen and sulphasalazine or methotrexate on hypothalamic-pituitary-adrenal axis activity in patients with rheumatoid arthritis
A.M. Eijsbouts, M.J. Kempers, F.H. Van Den Hoogen, R.F. Laan, A.R. Hermus, H. Ross, F.C. Sweep, L.B. Van De Putte

CER3796
2011,29,1
Pg. 0043-0049

Free to view

Geranylgeranyl-pyrophosphate regulates secretion of pentraxin 3 and monocyte chemoattractant protein-1 from rheumatoid fibroblast-like synoviocytes in distinct manners
K. Yokota, F. Miyoshi, K. Sato, Y. Asanuma, Y. Akiyama, T. Mimura

CER3984
2011,29,1
Pg. 0050-0056

Free to view

Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study
A. Ghirardello, D. Villalta, G. Morozzi, A. Afeltra, M. Galeazzi, R. Gerli, A. Mathieu, P.L. Meroni, F. Pregnolato, P. Migliorini, A. Radice, V. Riccieri, A. Ruffatti, G.D. Sebastiani, R.A. Sinico, A. Tincani, A. Doria

CER3990
2011,29,1
Pg. 0057-0064

Free to view

Leptin enhances MMP-1, MMP-3 and MMP-13 production in human osteoarthritic cartilage and correlates with MMP-1 and MMP-3 in synovial fluid from OA patients
A. Koskinen, K. Vuolteenaho, R. Nieminen, T. Moilanen, E. Moilanen

CER430
2011,29,1
Pg. 0065-0071

Free to view

Sustained improvement of health-related quality of life in patients with early rheumatoid arthritis: a ten-year follow-up study.
T. Uutela, P. Hannonen, H. Kautiainen, M. Hakala, A. Häkkinen

CER4049
2011,29,1
Pg. 0072-0079

Free to view

Identification and quantification of selected inflammatory genes modulated by leflunomide and prednisone treatment in early rheumatoid arthritis patients
M. Cutolo, B. Villaggio, R. Brizzolara, P. Montagna, F. Gallo, S. Moretti, S. Bonassi, A. Sulli, S. Soldano

Brief Papers

CER3918
2011,29,1
Pg. 0080-0084

Free to view

The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanercept.
E. Lubrano, A. Spadaro, A. Marchesoni, I. Olivieri, R. Scarpa, S. D`angelo, C. Salvarani, A. Mathieu, A. Cauli, N. Ferrara, P. Helliwell

CER3983
2011,29,1
Pg. 0085-0088

Free to view

Diagnostic value of antibodies against mutated citrullinated vimentin for rheumatoid arthritis.
E. Besada, C. Nikolaisen, H. Nossent

CER3987
2011,29,1
Pg. 0089-0092

Free to view

What predicts initiation of osteoporosis treatment after fractures: education organisation or patients' characteristics?
L. Semerano, X. Guillot, M. Rossini, E. Avice, T. Bégué, M. Wargon, M.-C. Boissier, N. Saidenberg-Kermanac`h

Case Reports

CER3971
2011,29,1
Pg. 0093-0095

Free to view

Intentional etanercept use during pregnancy for maintenance of remission in rheumatoid arthritis
C. Scioscia, M. Scioscia, M.G. Anelli, E. Praino, S. Bettocchi, G. Lapadula

Review

CER3778
2011,29,1
Pg. 0096-0103

Free to view

Clinical relevance of switching to a second tumour necrosis factor-alpha inhibitor after discontinuation of a first tumour necrosis factor-alpha inhibitor in rheumatoid arthritis: a systematic literature review and meta-analysis
A. Rémy, J. Avouac, L. Gossec, B. Combe

CER3820
2011,29,1
Pg. 0104-0110

Free to view

Growth in juvenile idiopathic arthritis: the role of inflammation
S. Gaspari, M.L. Marcovecchio, L. Breda, F. Chiarelli

Paediatric Rheumatology

CER3878
2011,29,1
Pg. 0111-0116

Free to view

The distribution of juvenile idiopathic arthritis in the eastern Mediterranean: results from the registry of the Turkish Paediatric Rheumatology Association
E. Demirkaya, S. Ozen, Y. Bilginer, N.A. Ayaz, B.B. Makay, E. Unsal, M. Erguven, H. Poyrazoglu, Ö. Kasapçopur, F. Gok, S. Akman, A. Balat, O. Cavkaytar, B. Kaya, A. Duzova, F. Ozaltin, R. Topaloglu, N. Besbas, A. Bakkaloglu, N. Arisoy, H. Ozdogan, S. Bakkaloglu, T. Turker

CER3832
2011,29,1
Pg. 0117-0124

Free to view

Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositis
D. Guseinova, A. Consolaro, L. Trail, C. Ferrari, A. Pistorio, N. Ruperto, A. Buoncompagni, C. Pilkington, S. Maillard, S.K. Oliveira, F. Sztajnbok, R. Cuttica, F. Corona, M.M. Katsicas, R. Russo, V. Ferriani, R. Burgos-Vargas, E. Solis-Vallejo, M. Bandeira, V. Baca, C. Saad-Magalhaes, C.A. Silva, R. Barcellona, L. Breda, R. Cimaz, R. Gallizzi, R. Garozzo, S. Martino, A. Meini, A. Stabile, A. Martini, A. Ravelli

CER3753
2011,29,1
Pg. 0125-0130

Free to view

High prevalence of primary immune deficiencies in children with autoimmune disorders.
J. Barsalou, C. Saint-Cyr, É. Drouin, F. Le Deist, E. Haddad

CER3861
2011,29,1
Pg. 0131-0139

Free to view

The 'head–to–head' comparison of etanercept and infliximab in treating children with juvenile idiopathic arthritis
L. Lamot, L.T. Bukovac, M. Vidovic, M. Frleta, M. Harjacek

Letter

CER4137
2011,29,1
Pg. 0140

Free to view

Coccygodinia as a possible presenting symptom of psoriatic arthritis
C. Palazzi, S. D`angelo, I. Olivieri

CER3906
2011,29,1
Pg. 0141

Free to view

De novo onset of arthritis in patients previously treated with efalizumab: an observational case series
M. Colina, G. Cianco, M. Khodeir, S. Sferra, P. Scanavacca, M. Corazza, A. Virgili, F. Trotta

CER3997
2011,29,1
Pg. 0142-0143

Free to view

Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis
L. Rodríguez-Rodríguez, M. García-Bermúdez, C. Gonzalez-Juanatey, T.R. Vazquez-Rodriguez, J.A. Miranda-Filloy, B. Fernandez-Gutierrez, J. Llorca, J. Martin, M.A. Gonzalez-Gay

CER4048
2011,29,1
Pg. 0144-0145

Free to view

MTHFR polymorphisms, C677T and A1298C, are not a genetic risk factor for liver stiffness index in methotrexate-treated rheumatoid arthritis patients
J.-Y. Choe, S.-H. Park, S.-K. Kim

CER4024
2011,29,1
Pg. 0146

Free to view

Low-back pain in adolescents: consider haematocolpometra by imperforate hymen in the case of a premenarchal girl
J.-C. Daboiko, M. Gbané-Koné, B. Ouattara

CER4067
2011,29,1
Pg. 0147

Free to view

Ineffectiveness of tumor necrosis factor-alpha inhibition in association with bisphosphonates for the treatment of cherubism
I. Pagnini, G. Simonini, M. Mortilla, T. Giani, L. Pascoli, R. Cimaz

Meeting Abstracts

CER4543
2011,29,1
Pg. 0149-0216

Free to view

CORA - Controversies in Rheumatology and Autoimmunity. March 10-12, 2011, Florence, Italy.
A. Doria, P. Sarzi-Puttini, Z. Szekanecz